Information acquisition system for joint marker for diagnosing PCOS (polycystic ovarian syndrome)

Abstract

The invention belongs to the technical field of medical information and discloses an information acquisition system for a joint marker for diagnosing PCOS (polycystic ovarian syndrome). The information acquisition system for the joint marker for diagnosing the PCOS comprises an excessive androgen measurement module, a serum extraction module, a central control module, a joint marker testing module, a treatment module, a data storage module and a display module. A detection kit can realize high-sensitivity and efficient detection and has the characteristics of low detection cost and good repeatability. Meanwhile, pharmaceutical composition provided by the treatment module and used for the excessive androgen type PCOS comprises medicinal materials including herba epimedii, fritillaria, fructus psoraleae, antler slices, hippocampus, tortoise plastron and the like, does not contain radix et rhizoma rhei or radix angelicae sinensis, notably reduces the androgen level of a patient, improvesgrowth of ovarian follicle and increases the ovulation rate and the pregnancy rate of the patient in the child-bearing period after being taken for a period of time.

Description

technical field [0001] The invention belongs to the technical field of medical information collection, and in particular relates to an information collection system of combined markers for diagnosing polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common complex endocrine and metabolic disorder in women of reproductive age, characterized by anovulation (ovulatory dysfunction or anovulation), hyperandrogenism (excess androgen production in women) and ovarian It is characterized by polycystic changes, and the main clinical manifestations are oligomenorrhea, infertility, hirsutism, acne, etc., accompanied by serious long-term complications such as type II diabetes, endometrial cancer, and cardiovascular disease, which plague women life. At present, the diagnosis of polycystic ovary syndrome mainly adopts the 2003 Rotterdam diagnostic criteria, anovulation or rare ovulation, clinical and / or biochemical hyperandrogenism and polycyst...

AI Technical Summary

Problems solved by technology

[0004] (1) These detection indicators can only provide reference significance for diagnosis, and the detection cost is high. At present, there is no complete collection system to identify and diagnose the serum markers of polycystic ovary syndrome

At the same time, the diagnosis and treatment of polycystic ovary syndrome is only symptomatic treatment, and there is no traditional Chinese medicine prescription for the treatment of different phenotypes of polycystic ovary syndrome

[0005] (2) The accuracy of existing serum sample classification methods is low

Images